<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37471432</PMID><DateCompleted><Year>2023</Year><Month>10</Month><Day>23</Day></DateCompleted><DateRevised><Year>2024</Year><Month>09</Month><Day>22</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">1932-6203</ISSN><JournalIssue CitedMedium="Internet"><Volume>18</Volume><Issue>7</Issue><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>PloS one</Title><ISOAbbreviation>PLoS One</ISOAbbreviation></Journal><ArticleTitle>Long Covid active case finding study protocol: A co-produced community-based pilot within the STIMULATE-ICP study (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways).</ArticleTitle><Pagination><StartPage>e0284297</StartPage><MedlinePgn>e0284297</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e0284297</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1371/journal.pone.0284297</ELocationID><Abstract><AbstractText Label="BACKGROUND AND AIM">Long Covid is a significant public health concern with potentially negative implications for health inequalities. We know that those who are already socially disadvantaged in society are more exposed to COVID-19, experience the worst health outcomes and are more likely to suffer economically. We also know that these groups are more likely to experience stigma and have negative healthcare experiences even before the pandemic. However, little is known about disadvantaged groups' experiences of Long Covid, and preliminary evidence suggests they may be under-represented in those who access formal care. We will conduct a pilot study in a defined geographical area in London, United Kingdom to test the feasibility of a community-based approach of identifying Long Covid cases that have not been clinically diagnosed and have not been referred to Long Covid specialist services. We will explore the barriers to accessing recognition, care, and support, as well as experiences of stigma and perceived discrimination.</AbstractText><AbstractText Label="METHODS">This protocol and study materials were co-produced with a Community Advisory Board (CAB) made up primarily of people living with Long Covid. Working with voluntary organisations, a study leaflet will be distributed in the local community to highlight Long Covid symptoms and invite those experiencing them to participate in the study if they are not formally diagnosed. Potential participants will be assessed according to the study's inclusion criteria and offered the opportunity to participate if they fit them. Awareness of Long Covid and associated symptoms, experiences of trying to access care, as well as stigma and discrimination will be explored through qualitative interviews with participants. Upon completion of the interviews, participants will be offered a referral to the local social prescribing team to receive support that is personalised to them potentially including, but not restricted to, liaising with their primary care provider and the regional Long Covid clinic.</AbstractText><CopyrightInformation>Copyright: &#xa9; 2023 Alwan et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Alwan</LastName><ForeName>Nisreen A</ForeName><Initials>NA</Initials><Identifier Source="ORCID">0000-0002-4134-8463</Identifier><AffiliationInfo><Affiliation>School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Southampton Biomedical Research Centre, University of Southampton and University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration Wessex, Southampton, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clutterbuck</LastName><ForeName>Donna</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>School of Primary Care, Population Sciences and Medical Education, University of Southampton, Southampton, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pantelic</LastName><ForeName>Marija</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Brighton and Sussex Medical School, University of Sussex, Falmer, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Social Policy and Intervention, University of Oxford, Oxford, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hayer</LastName><ForeName>Jasmine</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fisher</LastName><ForeName>Lere</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hishmeh</LastName><ForeName>Lyth</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-5851-2904</Identifier><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Heightman</LastName><ForeName>Melissa</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>University College London Hospitals NHS Trust, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Allsopp</LastName><ForeName>Gail</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Royal College of General Practitioners, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wootton</LastName><ForeName>Dan</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Liverpool University Hospitals NHS Foundation Trust, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Asad</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Manchester University Hospitals NHS Foundation Trust, Manchester, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hastie</LastName><ForeName>Claire</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Long Covid Support Charity, https://www.longcovid.org/, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jackson</LastName><ForeName>Monique</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rayner</LastName><ForeName>Clare</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brown</LastName><ForeName>Darren</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-4956-243X</Identifier><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Chelsea and Westminster Hospital NHS Foundation Trust, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Long COVID Physio, https://longcovid.physio/, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parrett</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Geraint</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0003-0551-8768</Identifier><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Kerry</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Clarke</LastName><ForeName>Rowan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mcfarland</LastName><ForeName>Sammie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Community Advisory Board (as person with lived experience of Long Covid), STIMULATE-ICP, London, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Long Covid Kids Charity, https://www.longcovidkids.org/, Salisbury, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gabbay</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>NIHR Applied Research Collaboration North West Coast, Liverpool, United Kingdom.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Primary Care and Mental Health, University of Liverpool, Liverpool, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banerjee</LastName><ForeName>Amitava</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-8741-3411</Identifier><AffiliationInfo><Affiliation>Institute of Health Informatics, University College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><CollectiveName>STIMULATE-ICP Consortium</CollectiveName></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>07</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>PLoS One</MedlineTA><NlmUniqueID>101285081</NlmUniqueID><ISSNLinking>1932-6203</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010865" MajorTopicYN="N">Pilot Projects</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D019033" MajorTopicYN="Y">Delivery of Health Care, Integrated</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006113" MajorTopicYN="N" Type="Geographic">United Kingdom</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>NAA is a co-investigator on the NIHR-funded HI-COVE study and has contributed in an advisory capacity to WHO and the EU Commission&#x2019;s Expert Panel on effective ways of investing in health meetings in relation to post-COVID-19 condition. GA is Interim CMO for NICE. GJ featured in two &#x2019;All Party Parliamentary Group&#x2019; sessions on Coronavirus. MJ is on the advisory group for the HI-COVE study. CR is Lead for Patient Participation and Involvement on NIHR-funded LoCoMotion study and is a Community Representative for the WHO-affiliated Access to Covid Therapies Accelerator. This does not alter our adherence to PL OS ONE policies on sharing data and materials.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>9</Month><Day>13</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>3</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>7</Month><Day>20</Day><Hour>19</Hour><Minute>14</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>7</Month><Day>20</Day><Hour>13</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>7</Month><Day>20</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37471432</ArticleId><ArticleId IdType="pmc">PMC10358953</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0284297</ArticleId><ArticleId IdType="pii">PONE-D-22-25470</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Nabavi N. Long covid: How to define it and how to manage it. BMJ. 2020;370:m3489. doi: 10.1136/bmj.m3489</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>Callard F, Perego E. How and why patients made Long Covid. Social Science &amp; Medicine. 2021;268:113426. doi: 10.1016/j.socscimed.2020.113426</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.socscimed.2020.113426</ArticleId><ArticleId IdType="pmc">PMC7539940</ArticleId><ArticleId IdType="pubmed">33199035</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus. https://www.who.int/publications/i/item/WHO-2019-nCoV-Post_COVID-19_condition-Clinical_case_definition-2021.1 (Accessed 21st March 2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">0</ArticleId></ArticleIdList></Reference><Reference><Citation>Office for National Statistics. Prevalence of ongoing symptoms following coronavirus (COVID-19) infection in the UK: 7th July 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/7july2022 (accessed 21st July 2022).</Citation></Reference><Reference><Citation>Office of National Statistics. Technical article: Updated estimates of the prevalence of post-acute symptoms among people with coronavirus (COVID-19) in the UK: 26 April 2020 to 1 August 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/technicalarticleupdatedestimatesoftheprevalenceofpostacutesymptomsamongpeoplewithcoronaviruscovid19intheuk/26april2020to1august2021 (accessed 22nd March 2022).</Citation></Reference><Reference><Citation>English indices of deprivation 2019. https://www.gov.uk/government/statistics/english-indices-of-deprivation-2019 (Accessed 13th January 2023).</Citation></Reference><Reference><Citation>Ziauddeen N, Gurdasani D, O&#x2019;Hara ME, Hastie C, Roderick P, Yao G, et al.. Characteristics and impact of Long Covid: Findings from an online survey. PLOS ONE. 2022;17(3):e0264331. doi: 10.1371/journal.pone.0264331</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0264331</ArticleId><ArticleId IdType="pmc">PMC8903286</ArticleId><ArticleId IdType="pubmed">35259179</ArticleId></ArticleIdList></Reference><Reference><Citation>Buttery S, Philip KEJ, Williams P, Fallas A, West B, Cumella A, et al.. Patient symptoms and experience following COVID-19: results from a UK-wide survey. BMJ Open Respiratory Research. 2021;8:e001075. doi: 10.1136/bmjresp-2021-001075</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001075</ArticleId><ArticleId IdType="pmc">PMC8572361</ArticleId><ArticleId IdType="pubmed">34732518</ArticleId></ArticleIdList></Reference><Reference><Citation>The King&#x2019;s Fund. The health of people from different ethnic groups in England. https://www.kingsfund.org.uk/publications/health-people-ethnic-minority-groups-england (Accessed 1st April 2022).</Citation></Reference><Reference><Citation>Public Health England. Health profile for England 2021. https://fingertips.phe.org.uk/static-reports/health-profile-for-england/hpfe_report.html (Accessed 1st April 2022).</Citation></Reference><Reference><Citation>Office for National Statistics. Updating ethnic contrasts in deaths involving the coronavirus (COVID-19), England: 10 January 2022 to 16 February 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/articles/updatingethniccontrastsindeathsinvolvingthecoronaviruscovid19englandandwales/10january2022to16february2022 (Accessed 7th April 2022).</Citation></Reference><Reference><Citation>Public Health England. Disparities in the risk and outcomes from COVID-19. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/892085/disparities_review.pdf (Accessed 23rd February 2022).</Citation></Reference><Reference><Citation>Office for National Statistics. Coronavirus case rates by socio-economic characteristics England 1 September 2020 to 10 December 2021. https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/coronaviruscovid19caseratesbysociodemographiccharacteristicsengland/1september2020to10december2021 (Accessed 30th March 2022).</Citation></Reference><Reference><Citation>Public Health England. Covid-19 deaths of people identified as having learning disabilities: a report. https://www.gov.uk/government/publications/covid-19-deaths-of-people-with-learning-disabilities (Accessed 31st March 2022).</Citation></Reference><Reference><Citation>Williamson EJ, McDonald HI, Bhaskaran K, Walker AJ, Bacon S, Davy S, et al.. Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform. BMJ. 2021;374(1592). doi: 10.1136/bmj.n1592</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1592</ArticleId><ArticleId IdType="pmc">PMC8278652</ArticleId><ArticleId IdType="pubmed">34261639</ArticleId></ArticleIdList></Reference><Reference><Citation>Heightman M, Prashar J, Hillman TE, Marks M, Livingston R, Ridsdale H, et al.. Post-COVID-19 assessment in a specialist clinical service: a 12-month, single-centre, prospective study in 1325 individuals. BMJ Open Respiratory Research. 2021;8:e001041. doi: 10.1136/bmjresp-2021-001041</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjresp-2021-001041</ArticleId><ArticleId IdType="pmc">PMC8587466</ArticleId><ArticleId IdType="pubmed">34764200</ArticleId></ArticleIdList></Reference><Reference><Citation>Hutchinson J, Checkland K, Munford L, Khavandi S, Sutton M. Long COVID in general practice: an analysis of the equity of NHS England&#x2019;s enhanced service specification. British Journal of General Practice. 2022;72(715):85&#x2013;86. doi: 10.3399/bjgp22X718505</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgp22X718505</ArticleId><ArticleId IdType="pmc">PMC8813118</ArticleId><ArticleId IdType="pubmed">35091414</ArticleId></ArticleIdList></Reference><Reference><Citation>Courtenay K, Cooper V. Covid 19: People with learning disabilities are highly vulnerable. They must be prioritised, and protected. BMJ. 2021;374(1701). doi: 10.1136/bmj.n1701</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1701</ArticleId><ArticleId IdType="pubmed">34261641</ArticleId></ArticleIdList></Reference><Reference><Citation>Kapadia D, Zhang J, Salway S. NHS Race &amp; Health Observatory. Ethnic Inequalities in Healthcare: A Rapid Evidence Review. 2022. https://www.nhsrho.org/wp-content/uploads/2022/02/RHO-Rapid-Review-Final-Report_v.7.pdf (Accessed 13th January 2023).</Citation></Reference><Reference><Citation>Kingstone T, Taylor AK, O&#x2019;Donnell CA, Atherton H, Blane DN, Chew-Graham CA. Finding the &#x201c;right&#x201d; GP: A qualitative study of the experiences of people with long-COVID. BJGP Open. 2020;4:bjgpopen20X101143. doi: 10.3399/bjgpopen20X101143</Citation><ArticleIdList><ArticleId IdType="doi">10.3399/bjgpopen20X101143</ArticleId><ArticleId IdType="pmc">PMC7880173</ArticleId><ArticleId IdType="pubmed">33051223</ArticleId></ArticleIdList></Reference><Reference><Citation>Ladds E, Rushforth A, Wieringa S, Taylor S, Rayner C, Husain L, et al.. Persistent symptoms after Covid-19: qualitative study of 114 &#x201c;long Covid&#x201d; patients and draft quality principles for services. BMC Health Services Research. 2020;20:1144. doi: 10.1186/s12913-020-06001-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12913-020-06001-y</ArticleId><ArticleId IdType="pmc">PMC7750006</ArticleId><ArticleId IdType="pubmed">33342437</ArticleId></ArticleIdList></Reference><Reference><Citation>Pantelic M, Ziauddeen N, Boyes M, O&#x2019;Hara ME, Hastie C, Alwan NA, et al.. Long Covid stigma: estimating burden and validating scale in a UK-based sample. PLOS ONE. 2022;17(11):e0277317. doi: 10.1371/journal.pone.0277317</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0277317</ArticleId><ArticleId IdType="pmc">PMC9683629</ArticleId><ArticleId IdType="pubmed">36417364</ArticleId></ArticleIdList></Reference><Reference><Citation>Forshaw D, Wall E, Prescott G, Dehbi H-M, Green A, Attree E, et al.. STIMULATE-ICP: A pragmatic, multi-centre, cluster randomised trial of an integrated care pathway with a nested, Phase III, open label, adaptive platform randomised drug trial in individuals with Long COVID: a structured protocol. PLOS ONE. 2023; 18(2) e0272472. doi: 10.1371/journal.pone.0272472</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0272472</ArticleId><ArticleId IdType="pmc">PMC9931100</ArticleId><ArticleId IdType="pubmed">36791116</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramasawmy M, Mu Y, Clutterbuck D, Pantelic M, Lip GYH, van der Feltz-Cornelis CM, et al.. STIMULATE-ICP-CAREINEQUAL&#x2014;Defining usual care and examining inequalities in Long Covid support: protocol for a mixed-methods study (part of STIMULATE-ICP: Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways). PLOS ONE.2022;17(8):e0271978.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9377596</ArticleId><ArticleId IdType="pubmed">35969597</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Feltz-Cornelis CM, Sweetman J, Allsopp G, Attree E, Crooks MG, Cuthbertson DJ, et al.. STIMULATE-ICP-Delphi (Symptoms, Trajectory, Inequalities and Management: Understanding Long-COVID to Address and Transform Existing Integrated Care Pathways Delphi): Study Protocol. PLOS ONE. 2022;17(11):e0277936. doi: 10.1371/journal.pone.0277936</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0277936</ArticleId><ArticleId IdType="pmc">PMC9710789</ArticleId><ArticleId IdType="pubmed">36449461</ArticleId></ArticleIdList></Reference><Reference><Citation>Hickey G, Brearley S, Coldham T, Denegri S, Green G, Staniszewska S, et al. Guidance on co-producing a research project. Southampton: INVOLVE. 2018. https://www.invo.org.uk/wp-content/uploads/2019/04/Copro_Guidance_Feb19.pdf (Accessed 08 April 2022).</Citation></Reference><Reference><Citation>Alwan NA. Lessons from Long COVID: working with patients to design better research. Nature Reviews Immunology. 2022;22:201&#x2013;202. doi: 10.1038/s41577-022-00692-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-022-00692-6</ArticleId><ArticleId IdType="pmc">PMC8853146</ArticleId><ArticleId IdType="pubmed">35169259</ArticleId></ArticleIdList></Reference><Reference><Citation>Redman S, Greenhalgh T, Adedokun L, Staniszewska S, Denegri S. Co-production of knowledge: the future. BMJ. 2021;372(434). doi: 10.1136/bmj.n434</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n434</ArticleId><ArticleId IdType="pmc">PMC7884902</ArticleId><ArticleId IdType="pubmed">33593753</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayer J. The Hidden Voices of Long Covid Project. https://mylongcoviddiaries.medium.com/the-hidden-voices-of-long-covid-5109fed0d79b (Accessed 08 April 2022).</Citation></Reference><Reference><Citation>Burke RM, Nliwasa M, Feasey HRA. Community-based active case-finding interventions for tuberculosis: a systematic review. The Lancet Public Health. 2021;6(5): E283&#x2013;E299. doi: 10.1016/S2468-2667(21)00033-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2468-2667(21)00033-5</ArticleId><ArticleId IdType="pmc">PMC8082281</ArticleId><ArticleId IdType="pubmed">33765456</ArticleId></ArticleIdList></Reference><Reference><Citation>Lepra. Our approach to Active Case Finding. https://www.lepra.org.uk/news/article/our-approach-to-active-case-finding (Accessed 09 May 2022).</Citation></Reference><Reference><Citation>Tingathe. Active Case Finding in Health Facilities: Promoting provider-initiated testing and counseling to identify new HIV cases. https://www.tingathe.org/active-case-finding.html (Accessed 09 May 2022).</Citation></Reference><Reference><Citation>Islington Public Health. Annual Public Health Report 2019&#x2013;20 Going further on Health Inequalities within Camden and Islington. https://democracy.islington.gov.uk/documents/s23126/1.%20Annual%20Public%20Health%20Report%20-%20Islington%20Health%20and%20Wellbeing%20Board%20with%20implications.pdf (Accessed 23rd February 2022).</Citation></Reference><Reference><Citation>Camden Council. Building Equal Foundations: Tackling the disproportionate impact of Covid-19 on Black, Asian and other ethnic communities in Camden. https://www.camden.gov.uk/documents/20142/181204604/Building+equal+foundations+full+report.pdf (Accessed 29th March 2022).</Citation></Reference><Reference><Citation>The King&#x2019;s Fund. What is social prescribing? https://www.kingsfund.org.uk/publications/social-prescribing (Accessed 09 May 2022).</Citation></Reference><Reference><Citation>Moffatt S, Steer M, Lawson S, Penn L, O&#x2019;Brien N. Link Worker social prescribing to improve health and well-being for people with long-term conditions: qualitative study of service user perceptions. BMJ Open. 2017;7(7):e015203. doi: 10.1136/bmjopen-2016-015203</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2016-015203</ArticleId><ArticleId IdType="pmc">PMC5541496</ArticleId><ArticleId IdType="pubmed">28713072</ArticleId></ArticleIdList></Reference><Reference><Citation>Voluntary Action Camden. Social prescribing: GUIDE FOR RESIDENTS. https://vac.org.uk/guides-and-resources/social-prescribing/ (Accessed 11th April 2022).</Citation></Reference><Reference><Citation>Davis HE, Assaf GS, McCorkell L, Wei H, Low RJ, Re&#x2019;em Y, et al.. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021; 38. doi: 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Aiyegbusi OL, Hughes SE, Turner G, Rivera SC, McMullan C, Chandan JS, et al.. Symptoms, complications and management of long COVID: a review. Journal of the Royal Society of Medicine. 2021;114(9):428&#x2013;442. doi: 10.1177/01410768211032850</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/01410768211032850</ArticleId><ArticleId IdType="pmc">PMC8450986</ArticleId><ArticleId IdType="pubmed">34265229</ArticleId></ArticleIdList></Reference><Reference><Citation>Long Covid Physio. Post-Exertional Symptom Exacerbation (PESE). https://longcovid.physio/post-exertional-malaise (Accessed 11th April 2022).</Citation></Reference><Reference><Citation>Camden Council. Camden Profile: January 2022. https://opendata.camden.gov.uk/w/9m7e-5qyt/jubw-4nes (19th May 2022).</Citation></Reference><Reference><Citation>Braun V, Clarke V. Thematic analysis. In Cooper H, Camic PM, Long DL, Panter AT, Rindskopf D, Sher KJ. (Eds.) APA handbook of research methods in psychology, Vol. 2. Research designs: Quantitative, qualitative, neuropsychological, and biological. American Psychological Association; 2012. p.57&#x2013;71.</Citation></Reference><Reference><Citation>Rockliffe L, Chorley AJ, Laura A. V. Marlow LAV, Forster AS. It&#x2019;s hard to reach the &#x201c;hard-to-reach&#x201d;: the challenges of recruiting people who do not access preventative healthcare services into interview studies. International Journal of Qualitative Studies on Health and Well-being. 2018; 13:1, 1479582. doi: 10.1080/17482631.2018.1479582</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482631.2018.1479582</ArticleId><ArticleId IdType="pmc">PMC6127841</ArticleId><ArticleId IdType="pubmed">29912650</ArticleId></ArticleIdList></Reference><Reference><Citation>Voluntary Action Camden. About us. https://vac.org.uk/about-us/ (Accessed 11th April 2022).</Citation></Reference><Reference><Citation>STIMULATE-ICP. STIMULATE-ICP. https://www.stimulate-icp.org/ (Accessed 22 May 2022).</Citation></Reference><Reference><Citation>Mathur R, Rentsch CT, Morton CE, Hulme WJ, Schultze A, MacKenna B, et al.. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021;397(10286). doi: 10.1016/S0140-6736(21)00634-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00634-6</ArticleId><ArticleId IdType="pmc">PMC8087292</ArticleId><ArticleId IdType="pubmed">33939953</ArticleId></ArticleIdList></Reference><Reference><Citation>Warner M, Burn S, Stoye G, Aylin PP, Bottle A, Propper C. Socioeconomic deprivation and ethnicity inequalities in disruption to NHS hospital admissions during the COVID-19 pandemic: a national observational study. BMJ Quality &amp; Safety. 2022;31(8):590&#x2013;8. doi: 10.1136/bmjqs-2021-013942</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjqs-2021-013942</ArticleId><ArticleId IdType="pmc">PMC8627367</ArticleId><ArticleId IdType="pubmed">34824162</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese L, Colloca L. Long COVID-19 and the Role of the Patient&#x2013;Clinician Interaction in Symptom Management. Journal of Patient Experience. 2022; 9. doi: 10.1177/23743735221077514</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/23743735221077514</ArticleId><ArticleId IdType="pmc">PMC8832111</ArticleId><ArticleId IdType="pubmed">35155749</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>